Development and pilot of an internationally standardized measure of cardiovascular risk management in European primary care

Sabine Ludt, Stephen Campbell, Jan Van Lieshout, Richard Grol, Joachim Szécsényi, Michel Wensing

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background
Primary care can play an important role in providing cardiovascular risk management in patients with established Cardiovascular Diseases (CVD), patients with a known high risk of developing CVD, and potentially for individuals with a low risk of developing CVD, but who have unhealthy lifestyles. To describe and compare cardiovascular risk management, internationally valid quality indicators and standardized measures are needed. As part of a large project in 9 European countries (EPA-Cardio), we have developed and tested a set of standardized measures, linked to previously developed quality indicators.

Methods
A structured stepwise procedure was followed to develop measures. First, the research team allocated 106 validated quality indicators to one of the three target populations (established CVD, at high risk, at low risk) and to different data-collection methods (data abstraction from the medical records, a patient survey, an interview with lead practice GP/a practice survey). Secondly, we selected a number of other validated measures to enrich the assessment. A pilot study was performed to test the feasibility. Finally, we revised the measures based on the findings.

Results
The EPA-Cardio measures consisted of abstraction forms from the medical-records data of established Coronary Heart Disease (CHD)-patients - and high-risk groups, a patient questionnaire for each of the 3 groups, an interview questionnaire for the lead GP and a questionnaire for practice teams. The measures were feasible and accepted by general practices from different countries.

Conclusions
An internationally standardized measure of cardiovascular risk management, linked to validated quality indicators and tested for feasibility in general practice, is now available. Careful development and pilot testing of the measures are crucial in international studies of quality of healthcare
Original languageEnglish
Pages (from-to)1-10
Number of pages10
JournalBMC Health Services Research
Volume11
Issue number70
DOIs
Publication statusPublished - 2011
Externally publishedYes

Fingerprint

Risk Management
Primary Health Care
Cardiovascular Diseases
General Practice
Medical Records
Interviews
Quality of Health Care
Health Services Needs and Demand
Coronary Disease
Life Style
Surveys and Questionnaires
Research
Lead

Cite this

Ludt, Sabine ; Campbell, Stephen ; Van Lieshout, Jan ; Grol, Richard ; Szécsényi, Joachim ; Wensing, Michel. / Development and pilot of an internationally standardized measure of cardiovascular risk management in European primary care. In: BMC Health Services Research. 2011 ; Vol. 11, No. 70. pp. 1-10.
@article{d9f1c2a4f6f141e38fce6cdcb5de8739,
title = "Development and pilot of an internationally standardized measure of cardiovascular risk management in European primary care",
abstract = "BackgroundPrimary care can play an important role in providing cardiovascular risk management in patients with established Cardiovascular Diseases (CVD), patients with a known high risk of developing CVD, and potentially for individuals with a low risk of developing CVD, but who have unhealthy lifestyles. To describe and compare cardiovascular risk management, internationally valid quality indicators and standardized measures are needed. As part of a large project in 9 European countries (EPA-Cardio), we have developed and tested a set of standardized measures, linked to previously developed quality indicators.MethodsA structured stepwise procedure was followed to develop measures. First, the research team allocated 106 validated quality indicators to one of the three target populations (established CVD, at high risk, at low risk) and to different data-collection methods (data abstraction from the medical records, a patient survey, an interview with lead practice GP/a practice survey). Secondly, we selected a number of other validated measures to enrich the assessment. A pilot study was performed to test the feasibility. Finally, we revised the measures based on the findings.ResultsThe EPA-Cardio measures consisted of abstraction forms from the medical-records data of established Coronary Heart Disease (CHD)-patients - and high-risk groups, a patient questionnaire for each of the 3 groups, an interview questionnaire for the lead GP and a questionnaire for practice teams. The measures were feasible and accepted by general practices from different countries.ConclusionsAn internationally standardized measure of cardiovascular risk management, linked to validated quality indicators and tested for feasibility in general practice, is now available. Careful development and pilot testing of the measures are crucial in international studies of quality of healthcare",
author = "Sabine Ludt and Stephen Campbell and {Van Lieshout}, Jan and Richard Grol and Joachim Sz{\'e}cs{\'e}nyi and Michel Wensing",
year = "2011",
doi = "10.1186/1472-6963-11-70",
language = "English",
volume = "11",
pages = "1--10",
journal = "BMC Health Services Research",
issn = "1472-6963",
publisher = "BioMed Central",
number = "70",

}

Development and pilot of an internationally standardized measure of cardiovascular risk management in European primary care. / Ludt, Sabine; Campbell, Stephen; Van Lieshout, Jan; Grol, Richard; Szécsényi, Joachim; Wensing, Michel.

In: BMC Health Services Research, Vol. 11, No. 70, 2011, p. 1-10.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Development and pilot of an internationally standardized measure of cardiovascular risk management in European primary care

AU - Ludt, Sabine

AU - Campbell, Stephen

AU - Van Lieshout, Jan

AU - Grol, Richard

AU - Szécsényi, Joachim

AU - Wensing, Michel

PY - 2011

Y1 - 2011

N2 - BackgroundPrimary care can play an important role in providing cardiovascular risk management in patients with established Cardiovascular Diseases (CVD), patients with a known high risk of developing CVD, and potentially for individuals with a low risk of developing CVD, but who have unhealthy lifestyles. To describe and compare cardiovascular risk management, internationally valid quality indicators and standardized measures are needed. As part of a large project in 9 European countries (EPA-Cardio), we have developed and tested a set of standardized measures, linked to previously developed quality indicators.MethodsA structured stepwise procedure was followed to develop measures. First, the research team allocated 106 validated quality indicators to one of the three target populations (established CVD, at high risk, at low risk) and to different data-collection methods (data abstraction from the medical records, a patient survey, an interview with lead practice GP/a practice survey). Secondly, we selected a number of other validated measures to enrich the assessment. A pilot study was performed to test the feasibility. Finally, we revised the measures based on the findings.ResultsThe EPA-Cardio measures consisted of abstraction forms from the medical-records data of established Coronary Heart Disease (CHD)-patients - and high-risk groups, a patient questionnaire for each of the 3 groups, an interview questionnaire for the lead GP and a questionnaire for practice teams. The measures were feasible and accepted by general practices from different countries.ConclusionsAn internationally standardized measure of cardiovascular risk management, linked to validated quality indicators and tested for feasibility in general practice, is now available. Careful development and pilot testing of the measures are crucial in international studies of quality of healthcare

AB - BackgroundPrimary care can play an important role in providing cardiovascular risk management in patients with established Cardiovascular Diseases (CVD), patients with a known high risk of developing CVD, and potentially for individuals with a low risk of developing CVD, but who have unhealthy lifestyles. To describe and compare cardiovascular risk management, internationally valid quality indicators and standardized measures are needed. As part of a large project in 9 European countries (EPA-Cardio), we have developed and tested a set of standardized measures, linked to previously developed quality indicators.MethodsA structured stepwise procedure was followed to develop measures. First, the research team allocated 106 validated quality indicators to one of the three target populations (established CVD, at high risk, at low risk) and to different data-collection methods (data abstraction from the medical records, a patient survey, an interview with lead practice GP/a practice survey). Secondly, we selected a number of other validated measures to enrich the assessment. A pilot study was performed to test the feasibility. Finally, we revised the measures based on the findings.ResultsThe EPA-Cardio measures consisted of abstraction forms from the medical-records data of established Coronary Heart Disease (CHD)-patients - and high-risk groups, a patient questionnaire for each of the 3 groups, an interview questionnaire for the lead GP and a questionnaire for practice teams. The measures were feasible and accepted by general practices from different countries.ConclusionsAn internationally standardized measure of cardiovascular risk management, linked to validated quality indicators and tested for feasibility in general practice, is now available. Careful development and pilot testing of the measures are crucial in international studies of quality of healthcare

U2 - 10.1186/1472-6963-11-70

DO - 10.1186/1472-6963-11-70

M3 - Article

VL - 11

SP - 1

EP - 10

JO - BMC Health Services Research

JF - BMC Health Services Research

SN - 1472-6963

IS - 70

ER -